Quest PharmaTech (CVE:QPT) Shares Down 25% – Here’s What Happened

Quest PharmaTech Inc. (CVE:QPT) traded down 25% during mid-day trading on Thursday . The stock traded as low as C$0.03 and last traded at C$0.03. 123,238 shares changed hands during mid-day trading, an increase of 414% from the average session volume of 23,982 shares. The stock had previously closed at C$0.04.

Quest PharmaTech Stock Performance

The firm has a fifty day moving average price of C$0.04 and a 200 day moving average price of C$0.04. The company has a debt-to-equity ratio of 4.35, a quick ratio of 0.52 and a current ratio of 0.40. The stock has a market cap of C$5.07 million, a PE ratio of -30.00 and a beta of 0.00.

Quest PharmaTech Company Profile

Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class.